SEC INSIDER TRANSACTIONS

ELI LILLY & Co (LLY) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

LLY · ELI LILLY & Co

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Stale snapshot · Covered: filings 2026-10-15 to 2026-11-13 · 13 filings · fetched 2026-11-13T18:38:39Z

View six-calendar-month insider history →

Recent reported activity

0purchase rows on this page

1sale rows on this page

23matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-11-10Filed 2026-11-10	Jonsson PatrikOfficer · EVP & President, LLY Int'l Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	G GiftCommon Stock · Non-derivative	704D	0	Direct	Form 4 ↗0001786054-26-000008
2026-11-03Filed 2026-11-04	Ricks David ADirector · Officer · President, Chair, and CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The amount reported includes (i) 4,990 shares of Eli Lilly and Company common stock transferred to the reporting person on May 14, 2026 as an annuity payment from the 2022 GRAT and (ii) 2,111 shares of Eli Lilly and Company common stock transferred to the reporting person on September 18, 2026 as an annuity payment from the 2025 GRAT, each a Grantor Retained Annuity Trust of which the reporting person is the trustee and each paid in accordance with its terms. F2 The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. F3 On September 18, 2026, 2,111 shares of Eli Lilly and Company common stock were transferred to the reporting person as an annuity payment in accordance with the terms of the Grantor Retained Annuity Trust, of which the reporting person is the trustee. F4 On May 14, 2026, 4,990 shares of Eli Lilly and Company common stock were transferred to the reporting person as an annuity payment in accordance with the terms of the Grantor Retained Annuity Trust, of which the reporting person is the trustee. References: F1	G GiftCommon Stock · Non-derivative	23,538D	0	Direct	Form 4 ↗0001538604-26-000006
2026-11-02Filed 2026-11-03	Hakim AnatOfficer · EVP, GC & Secretary Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on February 10, 2026. F2 The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein. F3 Amount reflects a net of 2,737.544 shares transferred from the Reporting Person's spouse to the Reporting Person. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	5,000D	1,402.52	IndirectBy spouse	Form 4 ↗0001685556-26-000008
2026-11-02Filed 2026-11-03	Skovronsky DanielOfficer · EVP, CS&PO & Pres. LRL Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. References:	G GiftCommon Stock · Non-derivative	119D	0	Direct	Form 4 ↗0001741474-26-000006
2026-11-01Filed 2026-11-03	Montarce LucasOfficer · EVP & CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. References: F1	M Exercise / conversionRestricted Stock Unit · Derivative	1,610D	0	Direct	Form 4 ↗0001752447-26-000006
2026-11-01Filed 2026-11-03	Montarce LucasOfficer · EVP & CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. References:	F WithholdingCommon Stock · Non-derivative	677.593D	1,417.54	Direct	Form 4 ↗0001752447-26-000006
2026-11-01Filed 2026-11-03	Montarce LucasOfficer · EVP & CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. References:	M Exercise / conversionCommon Stock · Non-derivative	1,610A	0	Direct	Form 4 ↗0001752447-26-000006
2026-11-01Filed 2026-11-03	Hernandez EdgardoOfficer · EVP & Pres., Mfg. Operations Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. References: F1	M Exercise / conversionRestricted Stock Unit · Derivative	2,530D	0	Direct	Form 4 ↗0001861052-26-000008
2026-11-01Filed 2026-11-03	Hernandez EdgardoOfficer · EVP & Pres., Mfg. Operations Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. References:	F WithholdingCommon Stock · Non-derivative	1,122.902D	1,417.54	Direct	Form 4 ↗0001861052-26-000008
2026-11-01Filed 2026-11-03	Hernandez EdgardoOfficer · EVP & Pres., Mfg. Operations Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. References:	M Exercise / conversionCommon Stock · Non-derivative	2,530A	0	Direct	Form 4 ↗0001861052-26-000008
2026-11-01Filed 2026-11-03	Dozier EricOfficer · EVP, Chief People Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. References: F1	M Exercise / conversionRestricted Stock Unit · Derivative	2,300D	0	Direct	Form 4 ↗0001955972-26-000010
2026-11-01Filed 2026-11-03	Dozier EricOfficer · EVP, Chief People Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. References:	F WithholdingCommon Stock · Non-derivative	1,019.361D	1,417.54	Direct	Form 4 ↗0001955972-26-000010
2026-11-01Filed 2026-11-03	Dozier EricOfficer · EVP, Chief People Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. References:	M Exercise / conversionCommon Stock · Non-derivative	2,300A	0	Direct	Form 4 ↗0001955972-26-000010
2026-11-01Filed 2026-11-03	Custer Kenneth L.Officer · EVP & President, Card Met Hlth Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. References: F1	M Exercise / conversionRestricted Stock Unit · Derivative	3,220D	0	Direct	Form 4 ↗0002071542-26-000006
2026-11-01Filed 2026-11-03	Custer Kenneth L.Officer · EVP & President, Card Met Hlth Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. References:	F WithholdingCommon Stock · Non-derivative	1,425.447D	1,417.54	Direct	Form 4 ↗0002071542-26-000006
2026-11-01Filed 2026-11-03	Custer Kenneth L.Officer · EVP & President, Card Met Hlth Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. References:	M Exercise / conversionCommon Stock · Non-derivative	3,220A	0	Direct	Form 4 ↗0002071542-26-000006
2026-11-01Filed 2026-11-03	Brown Adrienne SOfficer · EVP, President LLY Imm Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. References: F1	M Exercise / conversionRestricted Stock Unit · Derivative	2,530D	0	Direct	Form 4 ↗0002096888-26-000008
2026-11-01Filed 2026-11-03	Brown Adrienne SOfficer · EVP, President LLY Imm Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. References:	F WithholdingCommon Stock · Non-derivative	1,098.656D	1,417.54	Direct	Form 4 ↗0002096888-26-000008
2026-11-01Filed 2026-11-03	Brown Adrienne SOfficer · EVP, President LLY Imm Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. References:	M Exercise / conversionCommon Stock · Non-derivative	2,530A	0	Direct	Form 4 ↗0002096888-26-000008
2026-10-19Filed 2026-10-20	Fyrwald J ErikDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. References: F1	A Award / grantCommon Stock · Non-derivative	7.9951A	1,240.34	Direct	Form 4 ↗0000059478-26-000097
2026-10-19Filed 2026-10-20	LUCIANO JUAN RDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. References: F1	A Award / grantCommon Stock · Non-derivative	12.8325A	1,240.34	Direct	Form 4 ↗0000059478-26-000099
2026-10-19Filed 2026-10-20	Sulzberger GabrielleDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. References: F1	A Award / grantCommon Stock · Non-derivative	3.9976A	1,240.34	Direct	Form 4 ↗0001262388-26-000020
2026-10-19Filed 2026-10-20	Alvarez RalphDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. F2 The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. References: F1	A Award / grantCommon Stock · Non-derivative	10.0107A	1,240.34	Direct	Form 4 ↗0001310215-26-000019

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.